[6-K] Haleon plc Current Report (Foreign Issuer)

Rhea-AI Filing Summary

Haleon plc announced the purchase of 5,150,000 ordinary shares under the second tranche of its share buyback programme. The Company intends to hold the purchased shares as treasury shares. After settlement, registered share capital is 8,952,353,648 ordinary shares of £0.01 each, of which 28,187,545 are held as treasury shares, leaving 8,924,166,103 ordinary shares with voting rights. A full breakdown of individual trades is available via the provided London Stock Exchange link and on the Company website.

Positive

• Execution of announced buyback: Haleon purchased 5,150,000 shares under the second tranche of its programme.
• Shares held in treasury: Purchased shares will be held as treasury, preserving corporate flexibility.
• Regulatory disclosure provided: Company supplied a full trade breakdown link and updated voting rights figures.

Negative

• None.

Insights

Financial Analyst

TL;DR Buyback of 5.15m shares is a routine repurchase and modest relative to total share capital.

The transaction shows Haleon is executing its announced second tranche of a buyback programme and will hold shares in treasury, which reduces shares outstanding for dividend and EPS calculations but does not retire capital. The purchase of 5,150,000 shares compares to registered capital of 8.95 billion shares, indicating the tranche is small in proportion to total share count. The announcement includes a trade breakdown link for transaction-level detail, enabling verification of execution prices and volumes.

Corporate Governance Expert

TL;DR The company followed disclosure rules and updated voting rights figures after the buyback.

Haleon provided the required Market Abuse Regulation disclosure and updated the number of ordinary shares with voting rights to 8,924,166,103, which is the figure investors should use for notification thresholds under FCA rules. Holding purchased shares as treasury maintains flexibility for future use but means those shares currently carry no voting rights. The filing is procedural and compliant with reporting expectations.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2025

Commission File Number: 001-41411

Haleon plc

(Translation of registrant’s name into English)

Building 5, First Floor, The Heights,

Weybridge, Surrey, KT13 0NY

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

EXHIBIT INDEX

Exhibit Number	Description
99.1	23 September 2025 - “Transaction in Own Shares”

99.1

Haleon plc: Transaction in own shares

23 September 2025: Haleon plc (the "Company" or "Haleon") today announces the purchase of 5,150,000 ordinary shares of £0.01 each in the Company (the "Shares") under the second tranche of its share buyback programme announced on 31 July 2025.

	London Stock Exchange	CBOE (UK)/BXE	CBOE (UK)/CXE
Date of purchase:	22 September 2025	22 September 2025	22 September 2025
Number of Shares purchased:	3,507,000	1,000,000	643,000
Highest price paid per Share (p):	336.6000	334.0000	336.4000
Lowest price paid per Share (p):	332.7000	332.6000	332.7000
Volume weighted average price paid per Share (p):	333.9574	333.6379	333.9485

The Company intends to hold the purchased shares as treasury shares.

Following the settlement of the above, the Company's registered share capital is 8,952,353,648 ordinary shares of £0.01 each, of which 28,187,545 are held as treasury shares. Therefore, the number of ordinary shares with voting rights is 8,924,166,103 and this figure may be used by shareholders to determine if they are required to notify their interest, or a change to their interest, in Haleon under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a full breakdown of the individual trades is available at the link below:

http://www.rns-pdf.londonstockexchange.com/rns/3321A_1-2025-9-22.pdf

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

This announcement and individual trade breakdown will also be available on the Company's website at: www.haleon.com/investors.

Enquiries
Investors		Media
Jo Russell	+44 7787 392441	Zoë Bird	+44 7736 746167
Rakesh Patel	+44 7552 484646	Victoria Durman	+44 7894 505730
Email: investor-relations@haleon.com		Email: corporate.media@haleon.com

About Haleon

Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.

For more information, please visit www.haleon.com. 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		HALEON PLC (Registrant)
Date: September 23, 2025	By:	/s/ Amanda Mellor
		Name:	Amanda Mellor
		Title:	Company Secretary

FAQ

How many shares did Haleon (HLNCF) buy in this announcement?

Haleon purchased 5,150,000 ordinary shares under the second tranche of its buyback programme.

Will the purchased Haleon shares be cancelled or held in treasury?

The Company intends to hold the purchased shares as treasury shares, not cancel them.

What are Haleon's updated voting rights after the buyback?

Following settlement, the number of ordinary shares with voting rights is 8,924,166,103.

Where can I find the full breakdown of the individual trades?

A full breakdown is available at the London Stock Exchange link in the announcement and on www.haleon.com/investors.

How large is the buyback relative to Haleon's registered share capital?

The buyback of 5,150,000 shares is small relative to registered capital of 8,952,353,648 ordinary shares.